Fig. 2From: The use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may relate to the survival and walking ability in geriatric patients with hip fractures: a 1-year follow-up studyKaplan–Meier analysis of one-year survival patients grouped by the status of RAAS inhibitors using and hypertensionBack to article page